Hill Rom Holdings Inc (HRC) Return on Equity ROE from the fourth quarter 2021 to fourth quarter 2020 and annually, average high and low, overall ranking from Sep 30 2021 to Sep 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Hill rom Holdings Inc   (NYSE: HRC)

Hill Rom Holdings Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Hill Rom Holdings Inc in the fourth quarter 2021?
Hill rom Holdings Inc achieved a return on average equity (ROE) of 18.33 % in its fourth quarter 2021 a new company high.

ROE has advanced compared to 13.29% in the third quarter 2021, due to net income growth.

Within the Medical Equipment & Supplies industry 19 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 952, from total ROE ranking in the third quarter 2021 at 1323.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2021)
IV. Quarter		 (Jun 30 2021)
III. Quarter		 (Mar 31 2021)
II. Quarter		 (Dec 31 2020)
I. Quarter		 (Sep 30 2020)
IV. Quarter
Y / Y Equity Change -100 % 10.2 % 18.77 % 8.9 % -
Y / Y Net Income Change 25.94 % -47.6 % 85.71 % 47.74 % 51.97 %
Net Income (TTM) in Millions 249 238 282 242 223
Return On Equity (TTM) 18.33 % 13.29 % 16.17 % 14.47 % 13.63 %
HRC's Total Ranking # 952 # 1323 # 850 # 822 # 786
Equity (TTM) in Millions 0 1,821 1,840 1,763 1,726
Seq. Equity Change -100 % -1.02 % 4.34 % 2.14 % 4.46 %
Seq. Net Income Change 8.54 % -43.51 % 48.13 % 38.68 % -54.85 %

Back to HRC Management Effectiveness >> HRC's 5 Years Annual ROE >> Compare HRC ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 20
Sector # 100
Overall # 952

Return On Equity Statistics
High Average Low
18.33 %
11.15 %
3.29 %
(Sep 30 2021)   (Mar 31 2016)





HRC Annual Return On Equity (Sep 30 2021)
2021		 (Sep 30 2020)
2020		 (Sep 30 2019)
2019		 (Sep 30 2018)
2018		 (Sep 30 2017)
2017
Total Equity in Millions 0 1,726 1,573 1,616 1,366
Y / Y Equity Change -100 % 9.71 % -2.65 % 18.35 % 10.49 %
Net Income in Millions 249 223 152 252 132
Y / Y Net Income Change 11.43 % 46.52 % -39.7 % 90.78 % 7.74 %
Return On Equity 13220194.71 % 12.92 % 9.67 % 15.62 % 9.69 %

Back to HRC Management Effectiveness >> HRC's 5 Years Annual ROE >> Compare HRC ROE to its Competitors




Annual Roe Comment
In 2021 ROE improved to 13220194.71 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
HRC's' Return on Equity at Yahoo Finance
HRC's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for HRC's Competitors
Subscribers only: Roe for Hill Rom Holdings Inc 's Suppliers
Subscribers only: Return On Equity for HRC's Customers




Companies with similar Return On Equity at Sep 30 2021, within Healthcare Sector ROE
Antares Pharma Inc   50.17 %
The Cooper Companies Inc   49.67 %
Hologic Inc  49.33 %
Nrc Health  48.54 %
Sunlink Health Systems Inc   48.27 %
Collegium Pharmaceutical Inc   48.13 %
Zoetis Inc   46.85 %
Progyny Inc   46.02 %
3m Company  42.86 %
Talkspace Inc   40.42 %
Select Medical Holdings Corp  39.57 %
Lifevantage Corp  38.49 %
Gilead Sciences Inc   37.61 %
Organogenesis Holdings Inc   37.47 %
Encision Inc   37.27 %
Neurocrine Biosciences Inc   35.89 %
Chemed Corporation  35.36 %
Quest Diagnostics Inc  35.05 %
Elite Pharmaceuticals Inc   34.63 %
Dexcom Inc   33.65 %
Sage Therapeutics Inc   32.74 %
West Pharmaceutical Services Inc   30.94 %
Escalon Medical Corp   30.65 %
Edwards Lifesciences Corporation  29.68 %
Bionexus Gene Lab Corp   28.27 %
Pro dex Inc   27.81 %
Labcorp Holdings Inc   27.54 %
Biodelivery Sciences International Inc   27.47 %
Bruker Corporation  27.18 %
Sana Biotechnology Inc   26.99 %

Date modified: 2026-09-08T15:10:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.